Categories: News

NYSE Content Advisory: Pre-Market Update + Delta Air Lines Marks 100 Years

NEW YORK, Nov. 12, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Kristen Scholer delivers the pre-market update on November 12th

- Advertisement -
  • Stocks are up Wednesday morning after the DOW hit a record high on Tuesday, fueled by strong earnings and optimism around the potential end of the longest U.S. government shutdown.
  • House members return to Washington to vote on a spending package aimed at reopening the government, which could lead to the resumption of key federal data releases ahead of the Fed’s December meeting.
  • NYSE-listed Delta Air Lines rings the opening bell to mark its 100th anniversary. CEO Ed Bastian will join Lance Glinn for an episode of Inside the ICE House, and later ring the closing bell with NYSE-listed Uber CEO Dara Khosrowshahi.


Opening Bell


Delta Air Lines (NYSE: DAL) celebrates its 100th anniversary

- Advertisement -


Closing Bell


Delta (NYSE: DAL) and Uber (NYSE: UBER) celebrate their partnership

- Advertisement -


Click here to download the NYSE TV App

- Advertisement -

Video – https://mma.prnewswire.com/media/2821233/NYSE_Market_Update_Nov_12.mp4
Logo – https://mma.prnewswire.com/media/2581322/New_York_Stock_Exchange_Logo.jpg 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update–delta-air-lines-marks-100-years-302613106.html

- Advertisement -

Recent Posts

Deepak Group Goes Beyond Green with hands-On Mangrove Restoration

Deepak Group undertakes mangrove plantation drive on World Environment DaySustainable restoration along the Paniyadra coast,…

17 hours ago

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction,…

21 hours ago

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as…

21 hours ago

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)…

21 hours ago

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

June 05, 2026 20:13 ET  | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up…

21 hours ago